SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-059046
Filing Date
2024-07-03
Accepted
2024-07-03 16:15:21
Documents
13
Period of Report
2024-07-02
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0208878-8k_longeveron.htm   iXBRL 8-K 32567
  Complete submission text file 0001213900-24-059046.txt   208598

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lgvn-20240702.xsd EX-101.SCH 3021
3 XBRL LABEL FILE lgvn-20240702_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE lgvn-20240702_pre.xml EX-101.PRE 22363
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0208878-8k_longeveron_htm.xml XML 3794
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 241100307
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)